Biotech Values

[geocappy1]

Jq1234

I believe someone already pointed out that you may be confusing results of two different trials. The frontline study resulted in missed ORR and PFS endpoints. They are now awaiting MOS

The 2nd line trial had an ORR that was double the control group and the PFS was 40% and 50% better, respectively in the two Bavi dosed arms. They are awaiting the MOS data which also appears to be well outpacing the control group.